221
Views
2
CrossRef citations to date
0
Altmetric
Articles

Potential for repurposing oral hypertension/diabetes drugs to decrease asthma risk in obesity

, MD, MPHORCID Icon, , PhD, , MS, , MD, MSc, , MD, , MD & , MD show all
Pages 802-810 | Received 15 Nov 2021, Accepted 29 Jun 2022, Published online: 13 Jul 2022

References

  • Centers for Disease Control and Prevention. National health interview survey data, 2019, https://www.cdc.gov/asthma/nhis/2019/data.htm, last accessed on May 19, 2022. 2020.
  • Wang Y, Guo D, Chen X, Wang S, Hu J, Liu X. Trends in asthma among adults in the United States, National health and nutrition examination survey 2005 to 2018. Ann Allergy Asthma Immunol. 2022;129(1):71–78.e2. Epub 20220305. doi:10.1016/j.anai.2022.02.019.
  • Wong M, Forno E, Celedon JC. Asthma interactions between obesity and other risk factors. Ann Allergy Asthma Immunol. 2022. doi:10.1016/j.anai.2022.04.029.Epub 20220430.
  • Taylor EB. The complex role of adipokines in obesity, inflammation, and autoimmunity. Clin Sci (Lond). 2021;135(6):731–752. doi:10.1042/CS20200895. PubMed PMID: 33729498; PubMed Central PMCID: PMCPMC7969664.
  • Sood A, Shore SA. Adiponectin, leptin, and resistin in asthma: basic mechanisms through population studies. J Allergy (Cairo). 2013;2013:785835. doi:10.1155/2013/785835. Epub 2013/11/30. PubMed PMID: 24288549; PubMed Central PMCID: PMC3832971.
  • Sood A, Qualls C, Schuyler M, Thyagarajan B, Steffes MW, Smith LJ, Jacobs DR. Low serum adiponectin predicts future risk for asthma in women. Am J Respir Crit Care Med. 2012;186(1):41–47. Epub 2012/04/12. PubMed PMID: 22492987; PubMed Central PMCID: PMC3400996. doi:10.1164/rccm.201110-1767OC.
  • Sood A, Cui X, Qualls C, Beckett WS, Gross MD, Steffes MW, Smith LJ, Jacobs DR. Association between asthma and serum adiponectin concentration in women. Thorax. 2008;63(10):877–882. Epub 2008/04/09. PubMed PMID: 18390629; PubMed Central PMCID: PMC3616883. doi:10.1136/thx.2007.090803.
  • Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol. 2006;118(2):389–395. Epub 2006/08/08. doi:10.1016/j.jaci.2006.04.021.
  • Kytikova OY, Perelman JM, Novgorodtseva TP, Denisenko YK, Kolosov VP, Antonyuk MV, Gvozdenko TA. Peroxisome proliferator-activated receptors as a therapeutic target in asthma. PPAR Res. 2020;2020:8906968. Epub 2020/05/13. doi:10.1155/2020/8906968. PubMed PMID: 32395125; PubMed Central PMCID: PMCPMC7201810 publication of this paper.
  • Goto T, Nakayama R, Yamanaka M, Takata M, Takazawa T, Watanabe K, Maruta K, Nagata R, Nagamine J, Tsuchida A, et al. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/gamma modulator, on adipogenesis and glucose metabolism in diabetic obese mice. Exp Clin Endocrinol Diabetes. 2015;123(8):492–499. Epub 20150526. doi:10.1055/s-0035-1549965.
  • Wang QA, Zhang F, Jiang L, Ye R, An Y, Shao M, Tao C, Gupta RK, Scherer PE. Peroxisome proliferator-activated receptor gamma and its role in adipocyte homeostasis and thiazolidinedione-mediated insulin sensitization. Mol Cell Biol. 2018;38(10):e00677-17. Epub 2018/02/28. PubMed PMID: 29483301; PubMed Central PMCID: PMCPMC5954194. doi:10.1128/MCB.00677-17.
  • Hong F, Xu P, Zhai Y. The opportunities and challenges of peroxisome proliferator-activated receptors ligands in clinical drug discovery and development. IJMS. 2018;19(8):2189. Epub 2018/08/01. PubMed PMID: 30060458; PubMed Central PMCID: PMCPMC6121873. doi:10.3390/ijms19082189.
  • Arnold SV, Inzucchi SE, Echouffo-Tcheugui JB, Tang F, Lam CSP, Sperling LS, et al. Understanding contemporary use of thiazolidinediones. Circ Heart Fail. 2019;12(6):e005855. doi:10.1161/CIRCHEARTFAILURE.118.005855.
  • Zhao X, Dahal A, Yang Q, Yang Y, Ding Z, Wang J, Swai JD, Jiang W, Li X. Comparison of efficacies of commonly used hypertension treatment modalities: a retrospective study of 1900 participants in a hypertension clinic. Med Sci Monit. 2020;26:e921211. Epub 2020/05/01. PubMed PMID: 32352950; PubMed Central PMCID: PMCPMC7207006. doi:10.12659/MSM.921211.
  • Rinne ST, Feemster LC, Collins BF, Au DH, Perkins M, Bryson CL, O’Riordan TG, Liu C-F. Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study. Allergy Asthma Clin Immunol. 2014;10(1):34. Epub 2014/07/16. doi:10.1186/1710-1492-10-34. PubMed PMID: 25024717; PubMed Central PMCID: PMCPMC4094895.
  • Sandhu MS, Dimov V, Sandhu AK, Walters RW, Wichman T, Casale T. The use of the peroxisome proliferator-activated receptors gamma agonist rosiglitazone to treat airway hyperreactivity. Ann Allergy Asthma Immunol. 2012;109(1):75–77. Epub 2012/06/26. doi:10.1016/j.anai.2012.05.001.
  • Kim MJ, Im DS. Suppressive effects of type I angiotensin receptor antagonists, candesartan and irbesartan on allergic asthma. Eur J Pharmacol. 2019;852:25–33. Epub 2019/02/25. doi:10.1016/j.ejphar.2019.02.035.
  • Su VY-F, Ko S-W, Chang Y-L, Chou Y-C, Lee H-C, Yang K-Y, Chou K-T, Hsu C-C. Cardiovascular medication use and risk of acute exacerbation in patients with asthma-COPD overlap (CVACO study). Allergy Asthma Immunol Res. 2022;14(3):314–327. Epub 2022/05/14. PubMed PMID: 35557496; PubMed Central PMCID: PMCPMC9110917. doi:10.4168/aair.2022.14.3.314.
  • Fisman EZ, Tenenbaum A. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol. 2014;13:103. Epub 20140623. doi:10.1186/1475-2840-13-103. PubMed PMID: 24957699; PubMed Central PMCID: PMCPMC4230016.
  • Legere RM, Taylor DR, Davis JL, Bello K, Parker C, Judd RL, Wooldridge AA. Pharmacodynamic effects of pioglitazone on high molecular weight adiponectin concentrations and insulin response after oral sugar in equids. J Equine Vet Sci. 2019;82:102797. Epub 20190924. doi:10.1016/j.jevs.2019.102797.
  • Mukherjee M, Stoddart A, Gupta RP, Nwaru BI, Farr A, Heaven M, Fitzsimmons D, Bandyopadhyay A, Aftab C, Simpson CR, et al. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med. 2016;14(1):113. Epub 2016/08./30. doi:10.1186/s12916-016-0657-8. PubMed PMID: 27568881; PubMed Central PMCID: PMCPMC5002970.
  • Faber J, Fonseca LM. How sample size influences research outcomes. Dental Press J Orthod. 2014;19(4):27–29. Epub 2014/10/04. doi:10.1590/2176-9451.19.4.027-029.ebo. PubMed PMID: 25279518; PubMed Central PMCID: PMCPMC4296634.
  • Zhou X, Xie Y. Heterogeneous treatment effects in the presence of self-selection: a propensity score perspective. Sociol Methodol. 2020;50(1):350–385. Epub 20190802. doi:10.1177/0081175019862593. PubMed PMID: 34121778; PubMed Central PMCID: PMCPMC8195266.
  • Baker SG. Maximum likelihood estimation with missing outcomes: from simplicity to complexity. Stat Med. 2019;38(22):4453–4474. Epub 2019/08/09. doi:10.1002/sim.8319. PubMed PMID: 31392751; PubMed Central PMCID: PMCPMC6879193.
  • Sood A, Seagrave J, Herbert G, Harkins M, Alam Y, Chiavaroli A, Shohreh R, Montuschi P, Campen M, Harmon M, et al. High sputum total adiponectin is associated with low odds for asthma. J Asthma. 2014;51(5):459–466. Epub 2014/01/23. doi:10.3109/02770903.2014.882934.
  • Dixon AE, Subramanian M, DeSarno M, Black K, Lane L, Holguin F. A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity. Respir Res. 2015;16:143. Epub 2015/11/28. doi:10.1186/s12931-015-0303-6. PubMed PMID: 26610598; PubMed Central PMCID: PMC4661996.
  • Aaron SD, Vandemheen KL, Boulet L-P, McIvor RA, Fitzgerald JM, Hernandez P, Lemiere C, Sharma S, Field SK, Alvarez Gnz G, Canadian Respiratory Clinical Research Consortium, et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ. 2008;179(11):1121–1131. Epub 2008/11/19. doi:10.1503/cmaj.081332.
  • Rivera AC, Powell TM, Boyko EJ, Lee Rac U, Faix DJ, Luxton DD, Rull RP, Millennium Cohort Study Team. New-onset asthma and combat deployment: findings from the millennium cohort study. Am J Epidemiol. 2018;187(10):2136–2144. doi:10.1093/aje/kwy112. PubMed PMID: 29893775; PubMed Central PMCID: PMCPMC6166206.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.